Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Twist Bioscience Corporation (TWST), most recent 12 months reported: revenue $431.8M, net loss $136.72M, free cash flow -$98.12M. Latest balance sheet on file: liquid cash $166.84M, total debt $15M, net cash $151.84M. From SEC filings. More on Twist Bioscience Corporation: Revenue · Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): REPLIGEN CORP · TARSUS PHARMACEUTICALS, INC. · ADMA BIOLOGICS, INC. · Krystal Biotech, Inc. · Immunocore Holdings plc · NOVAVAX INC · MeiraGTx Holdings plc · IOVANCE BIOTHERAPEUTICS, INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.